Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
Background Anti-thymocyte globulin (ATG) as induction therapy in renal transplantation is facing the dilemma of reducing the incidence of acute rejection (AR) and delayed graft function (DGF) or increasing risks of infection and malignancy. The purpose of this study was to delineate the safety and e...
Main Authors: | Hui-Ying Liu, Yuan-Tso Cheng, Hao Lun Luo, Chiang-Chi Huang, Chien Hsu Chen, Yuan-Chi Shen, Wen-Chin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/7274.pdf |
Similar Items
-
Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation
by: Xin Chen, et al.
Published: (2023-12-01) -
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01) -
Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
by: Paolo Malvezzi, et al.
Published: (2015-10-01) -
Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
by: Hyung Duk Kim, et al.
Published: (2023-09-01) -
Evaluating the Impact of Post-Transplant Cyclophosphamide and Anti-Thymocyte Globulin on CMV Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review
by: Jarosław Dybko, et al.
Published: (2023-12-01)